Pregnancy and liver adenoma management: PALM-study

BMC Gastroenterology

Volumn 12, Issue , 2012, Pages

  van Aalten, Susanna M ^a   Bröker, Mirelle E E ^a   Busschbach, J J V ^a   de Koning, Harry J ^a   de Man, Robert A ^a   Steegers, Eric A P ^a   Steyerberg, Ewout W ^a   Terkivatan, Turkan ^a   IJzermans, Jan N M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL STUDY; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DIABETES MELLITUS; FEMALE; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; LABOR; LIVER ADENOMA; MULTICENTER STUDY; NETHERLANDS; ONLINE SYSTEM; OUTCOME ASSESSMENT; PREGNANCY; PROSPECTIVE STUDY; PUERPERIUM; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY;

ADENOMA, LIVER CELL; ADOLESCENT; ADULT; COMORBIDITY; DECISION MAKING; DIABETES MELLITUS; FEMALE; HUMANS; LIVER NEOPLASMS; NETHERLANDS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 84863002359     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-12-82     Document Type: Article

References (32)

1. Reddy KR, Schiff ER. Approach to a liver mass. Semin Liver Dis 1993, 13(4):423-435.
2. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 1979, 242(7):644-648. 10.1001/jama.1979.03300070040020, 221698.
3. Baum JK, Bookstein JJ, Holtz F, Klein EW. Possible association between benign hepatomas and oral contraceptives. Lancet 1973, 2(7835):926-929.
4. Baek S, Sloane CE, Futterman SC. Benign liver cell adenoma associated with use of oral contraceptive agents. Ann Surg 1976, 183(3):239-242. 10.1097/00000658-197603000-00003, 1344229, 176959.
5. Horvath E, Kovacs K, Ross RC. Letter: Benign hepatoma in a young woman on contraceptive steroids. Lancet 1974, 1(7853):357-358.
6. Lingeman CH. Letter: Liver-cell neoplasms and oral contraceptives. Lancet 1974, 1(7846):64.
7. Nissen ED, Kent DR, Nissen SE. Etiologic factors in the pathogenesis of liver tumors associated with oral contraceptives. Am J Obstet Gynecol 1977, 127(1):61-66.
8. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Tyler CW. The association between oral contraception and hepatocellular adenoma-a preliminary report. Int J Gynaecol Obstet 1977, 15(2):143-144.
9. Stoot JH, Coelen RJ, De Jong MC, Dejong CH. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 2010, 12(8):509-522.
10. Aseni P, Sansalone CV, Sammartino C, Benedetto FD, Carrafiello G, Giacomoni A, Osio C, Vertemati M, Forti D. Rapid disappearance of hepatic adenoma after contraceptive withdrawal. J Clin Gastroenterol 2001, 33(3):234-236. 10.1097/00004836-200109000-00015, 11500616.
11. Buhler H, Pirovino M, Akobiantz A, Altorfer J, Weitzel M, Maranta E, Schmid M. Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 1982, 82(4):775-782.
12. Edmondson HA, Reynolds TB, Henderson B, Benton B. Regression of liver cell adenomas associated with oral contraceptives. Ann Intern Med 1977, 86(2):180-182.
13. Steinbrecher UP, Lisbona R, Huang SN, Mishkin S. Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives. Dig Dis Sci 1981, 26(11):1045-1050. 10.1007/BF01314771, 6271517.
14. Terkivatan T, de Wilt JH, de Man RA, van Rijn RR, Tilanus HW, IJ JN. Treatment of ruptured hepatocellular adenoma. Br J Surg 2001, 88(2):207-209. 10.1046/j.1365-2168.2001.01648.x, 11167868.
15. Terkivatan T, de Wilt JH, de Man RA, van Rijn RR, Zondervan PE, Tilanus HW, IJ JN. Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 2001, 136(9):1033-1038. 10.1001/archsurg.136.9.1033, 11529826.
16. Ault GT, Wren SM, Ralls PW, Reynolds TB, Stain SC. Selective management of hepatic adenomas. Am Surg 1996, 62(10):825-829.
17. Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, Bedossa P, Belghiti J. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 2009, 137(5):1698-1705. 10.1053/j.gastro.2009.07.061, 19664629.
18. van Aalten SM, Terkivatan T, de Man RA, van der Windt DJ, Kok NF, Dwarkasing R, Ijzermans JN. Diagnosis and treatment of hepatocellular adenoma in the Netherlands: similarities and differences. Dig Surg 2010, 27(1):61-67. 10.1159/000268587, 20357453.
19. van der Windt DJ, Kok NF, Hussain SM, Zondervan PE, Alwayn IP, de Man RA, IJ JN. Case-orientated approach to the management of hepatocellular adenoma. Br J Surg 2006, 93(12):1495-1502. 10.1002/bjs.5511, 17051603.
20. Cobey FC, Salem RR. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 2004, 187(2):181-191. 10.1016/j.amjsurg.2003.11.016, 14769302.
21. Noels JE, van Aalten SM, van der Windt DJ, Kok NFM, de Man RA, Terkivatan T, IJzermans JNM. Management of Hepatocellular Adenoma During Pregnancy. J Hepatol 2011, 54(3):553-8. 10.1016/j.jhep.2010.07.022, 21094555.
22. Evers AC, Brouwers HA, Hukkelhoven CW, Nikkels PG, Boon J, van Egmond-Linden A, Hillegersberg J, Snuif YS, Sterken-Hooisma S, Bruinse HW, et al. Perinatal mortality and severe morbidity in low and high risk term pregnancies in the Netherlands: prospective cohort study. BMJ 2010, 341:c5639. 10.1136/bmj.c5639, 21045050.
23. Amelink-Verburg MP, Buitendijk SE. Pregnancy and labour in the Dutch maternity care system: what is normal? The role division between midwives and obstetricians. J Midwifery Womens Health 2010, 55(3):216-225. 10.1016/j.jmwh.2010.01.001, 20434081.
24. Bioulac-Sage P, Balabaud C, Zucman-Rossi J. Subtype classification of hepatocellular adenoma. Dig Surg 2010, 27(1):39-45. 10.1159/000268406, 20357450.
25. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003, 41(5):582-592.
26. Yumi H. Guidelines for diagnosis, treatment, and use of laparoscopy for surgical problems during pregnancy: this statement was reviewed and approved by the Board of Governors of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), September 2007. It was prepared by the SAGES Guidelines Committee. Surg Endosc 2008, 22(4):849-861.
27. Hua X, Zhu LP, Li R, Zhong H, Xue YF, Chen ZH. Effects of diagnostic contrast-enhanced ultrasound on permeability of placental barrier: a primary study. Placenta 2009, 30(9):780-784. 10.1016/j.placenta.2009.06.009, 19640583.
28. Kort B, Katz VL, Watson WJ. The effect of nonobstetric operation during pregnancy. Surg Gynecol Obstet 1993, 177(4):371-376.
29. Visser BC, Glasgow RE, Mulvihill KK, Mulvihill SJ. Safety and timing of nonobstetric abdominal surgery in pregnancy. Dig Surg 2001, 18(5):409-417. 10.1159/000050183, 11721118.
30. Parangi S, Levine D, Henry A, Isakovich N, Pories S. Surgical gastrointestinal disorders during pregnancy. Am J Surg 2007, 193(2):223-232. 10.1016/j.amjsurg.2006.04.021, 17236852.
31. Wilson CH, Manas DM, French JJ. Laparoscopic Liver Resection for Hepatic Adenoma in Pregnancy. J Clin Gastroenterol 2011, 45(9):828-33. 10.1097/MCG.0b013e3181f97747, 20962668.
32. Fujita S, Kushihata F, Herrmann GE, Mergo PJ, Liu C, Nelson D, Fujikawa T, Hemming AW. Combined hepatic resection and radiofrequency ablation for multiple hepatic adenomas. J Gastroenterol Hepatol 2006, 21(8):1351-1354. 10.1111/j.1440-1746.2006.03184.x, 16872326.